Food and biotech company Ajinomoto has announced it will invest in SuperMeat as a corporate venture capital project. This partnership aims to tackle ongoing food and health issues by creating and validating viable production and value chain solutions for cell-cultured meat. The market is expected to grow by $25 billion by 2030, which means that there’s a push for players in the industry to scale rapidly.

They are planning to establish an open platform that will enable for the commercialization of cultivated meat. One of its first projects is to develop cell growth media that contains nutrients needed for animal cell growth. Ingredients applicable to cultivated meat, such as recombinant proteins will also be created to help support cell growth and differentiation.

“In the past year, we have made tremendous strides in product development and scale, setting us up for industrial commercialization,” says Ido Savir, CEO of SuperMeat. “We are thrilled to partner with Ajinomoto, a global leader in food and biotechnology, to bring to market scalable, affordable and delicious cultivated meat products in poultry and beyond.”

“We look forward to partnering with SuperMeat, whose mission and values align closely with our own, to bring the world more viable sustainable options as alternative protein,” said Hiroshi Shiragami, Executive Officer & Senior Vice President, Chief Innovation Officer of Ajinomoto Co. “SuperMeat has an impressive track record of producing high-quality cultivated poultry products that have the potential to impact the global meat supply chain and meet consumer demand.”

SuperMeat’s proprietary technology enables muscle, fat and connective tissue to grow in a tissue-like structure. This efficient and scalable process yields a delicious alternative that offers the same nutritional and organoleptic properties of traditional meat products.

This partnership also aims to solidify overall acceptance among consumers and manufacturers and consider cultivated meat as a viable solution to issues surrounding health and protein supply.